Science advances · 2022
Mucus concentration-dependent biophysical abnormalities unify submucosal gland and superficial airway dysfunction in cystic fibrosis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kato Takafumi, Radicioni Giorgia, Papanikolas Micah J, Stoychev Georgi V, Markovetz Matthew R, Aoki Kazuhiro, Porterfield Melody, Okuda Kenichi, Barbosa Cardenas Selene M, Gilmore Rodney C, Morrison Cameron B, Ehre Camille, Burns Kimberlie A, White Kristen K, Brennan Tara A, Goodell Henry P, Thacker Holly, Loznev Henry T, Forsberg Lawrence J, Nagase Takahide, Rubinstein Michael, Randell Scott H, Tiemeyer Michael, Hill David B, Kesimer Mehmet, O'Neal Wanda K, Ballard Stephen T, Freeman Ronit, Button Brian, Boucher Richard C
Аннотация
Cystic fibrosis (CF) is characterized by abnormal transepithelial ion transport. However, a description of CF lung disease pathophysiology unifying superficial epithelial and submucosal gland (SMG) dysfunctions has remained elusive. We hypothesized that biophysical abnormalities associated with CF mucus hyperconcentration provide a unifying mechanism. Studies of the anion secretion-inhibited pig airway model of CF revealed elevated SMG mucus concentrations, osmotic pressures, and SMG mucus accumulation. Human airway studies revealed hyperconcentrated CF SMG mucus with raised osmotic pressures and cohesive forces predicted to limit SMG mucus secretion/release. Using proline-rich protein 4 (PRR4) as a biomarker of SMG secretion, CF sputum proteomics analyses revealed markedly lower PRR4 levels compared to healthy and bronchiectasis controls, consistent with a failure of CF SMGs to secrete mucus onto airway surfaces. Raised mucus osmotic/cohesive forces, reflecting mucus hyperconcentration, provide a unifying mechanism that describes disease-initiating mucus accumulation on airway surfaces and in SMGs of the CF lung.